Synthesis, spectroscopic and luminescent properties of nanosized powders of yttrium phosphates doped with Er3+ ions

Here, we report synthesis of pure crystalline nanopowders of yttrium orthophosphate Y 0.95 Er 0.05 PO 4 with xenotime-type structure and hydrate of yttrium orthophosphate Y 0.95 Er 0.05 PO 4 ⋅0.8H 2 O with rhabdophane-type structure using microwave-hydrothermal treatment of freshly precipitated gels...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology 2014-03, Vol.16 (3), Article 2326
Hauptverfasser: Ryabochkina, Polina A., Antoshkina, Svetlana A., Vanetsev, Alexander S., Sildos, Ilmo, Gaitko, Olga M., Kyashkin, Vladimir M., Ushakov, Sergey N., Panov, Andrey A., Tabachkova, Natalie Yu, Nishchev, Konstantin N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Here, we report synthesis of pure crystalline nanopowders of yttrium orthophosphate Y 0.95 Er 0.05 PO 4 with xenotime-type structure and hydrate of yttrium orthophosphate Y 0.95 Er 0.05 PO 4 ⋅0.8H 2 O with rhabdophane-type structure using microwave-hydrothermal treatment of freshly precipitated gels. To establish phase composition of the synthesized nanopowders, we have carried out XRD analysis. Also, we have investigated their morphology by means of TEM and SAXS. We have registered scattered reflection spectra for synthesized Y 0.95 Er 0.05 PO 4 and Y 0.95 Er 0.05 PO 4 ⋅0.8H 2 O powders. Also, we have obtained luminescent spectra of these nanocrystalline samples for 4 I 13/2  →  4 I 15/2 transition of Er 3+ ion with excitation of 4 I 11/2 level. We have proposed the mode of application of nanocrystalline powders Y 0.95 Er 0.05 PO 4 and Y 0.95 Er 0.05 PO 4 ⋅0.8H 2 O for the development of composite materials based on polymer capsules that are being used in targeted drug delivery.
ISSN:1388-0764
1572-896X
DOI:10.1007/s11051-014-2326-1